medigraphic.com
SPANISH

Veterinaria México

  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

1997, Number 4

<< Back Next >>

Vet Mex 1997; 28 (4)

In vitro and in vivo fascioliscide efficary of two chemical compounds in sheep

lbarra VF, García SE, Fernández RM, Vera MY, Castillo BR, Hernández CA
Full text How to cite this article

Language: English/Spanish
References: 16
Page: 291-296
PDF size: 495.99 Kb.


Key words:

FASCIOLA HEPATICA, EXPERIMENTAL CHEMOTHERAPY, SHEEP.

ABSTRACT

Fascioliscide activity of 6-chloro-5-(1-naphtoxy)-2-methyltiobencimidazol called Alfa and 6-chloro-5-(2- naphtoxy)-2-methyltiobencimidazol called Beta was evaluated under in vitro and in vivo conditions in sheep. In vitro efficacy was determined for both compounds using excisted Fasciola hepatica metacercariae at concentrations of 50, 10, 3.33, 1.11 and 0.37 mg/L. Efficacy was assessed by comparing the survival of the flukes after a four day period of the exposition to the chemicals. Compound Alfa showed an efficacy of 100, 100, 77.5, 0.0 and 0.0%, and compound Beta of 100, 67.5, 1.75, 0.0 and 0.0%, respectively. For the in vivo evaluation, forty five crossbred sheep were used and infected with 150 metacercariae each. Eight weeks after the initial infection, when all animals were positive to Fasciola eggs, the sheep were randomly divided in 5 groups of 9 animals each. Groups 1 and 2 were treated orally with 10 and 15 mg/kg of compound Alfa, respectively. Groups 3 and 4 were dosed orally with 10 and 15 mg/kg of compound Beta, respectively. Group 5 remained as the non-treated control. Two weeks after the treatment, all sheep were euthanized in order to collect and count the flukes in the liver. The efficacy was determined as the percentage of flukes reduced in the treated groups in comparison to the control one. Results showed an efficacy of 80.6% and 86.9% for Groups 1 and 2 respectively, and of 0.0% for Groups 3 and 4, respectively. Measurements of the fluke's length and liver weight did not show any adverse effects attributable to the treatments. It is concluded that under in vitro and in vivo conditions, compound Alfa exerted remarkable efficacy, and compound Beta only showed an acceptable one under the in vitro testing.


REFERENCES

  1. Soulsby EJL. Parasitología y enfermedades parasitarias de los animales domésticos. 7a ed. México (DF): Nueva Editorial Interamericana, 1987.

  2. Urquhart GM, Armour J, Duncan JL, Dunn AM, Jennings FW. Veterinary parasitology. 5th ed. London: Longman Scientific & Technical, 1992.

  3. Bruce JI. New anthelmintics. Int J Parasitol 1987;17:131-136.

  4. Gibson TE. Factors influencing the application of anthelmintics in practice. Vet Parasitol 1980;6:241-254.

  5. Ibarra-Velarde VF, Vera-Montenegro Y, Hernández-Campos A, Castillo-Bocanegra R. Síntesis de un compuesto fasciolicida experimental y su evaluación in vitro e in vivo en conejos. Téc Pecu Méx 1995;33:17-24.

  6. Ibarra-Velarde OF, Vera-Montenegro Y, Olazarán-Jenkins S, Hernández-Campos A, Castillo-Bocanegra R. Fasciolinip-1: Eficacia fasciolicida experimental en ovinos. Rev Latinoam Microbiol 1995;37:171-178.

  7. Ibarra-Velarde OF, Vera-Montenegro Y, Olazarán-Jenkins S, Hernández-Campos A, Castillo-Bocanegra R. Fasciolinip-2: Eficacia fasciolicida experimental en ovinos. Parasitología Día 1995;19:113-118.

  8. Ibarra-Velarde VE, Vera-Montenegro Y, Hernández-Campos A, Castillo-Bocanegra R. Eficacia de un compuesto experimental contra Fasciola hepatica juvenil y adulta en ganado ovino. Vet Méx 1996;27:119-122.

  9. Ibarra OF, Jenkins DC. An in vitro screen for new fasciolicidal agents. Z Parasitenk 1984;70:655-671.

  10. Nemeseri H. Diagnóstico parasitológico veterinario. Zaragoza (España) : Acribia, 1974.

  11. Wood IB, Amaral NK, Bairden K, Duncan JL, Kassai J, Malone JB, Pankavich JA, Reinecke RK, Slocombe O, Taylor SM, Vercruysse J. World Association for the Advancement of Veterinary Parasitology (W.A.A.V.P) second edition of guidelines for evaluating the efficacy of anthelmintics in ruminants (bovine, ovine and caprine). Vet Parasitol 1995;58:181-213.

  12. Burr-Foster Q. Analysis of variance. In: Anderson VH, McLean RA, editors. Design of experiments: a realistic approach. New York: Marcel-Decker, 1974:46-64.

  13. Ibarra-Velarde OF. Chemotherapeutical studies on helminths (thesis). London: Univ Brunel, 1983.

  14. Tuner RJ, Armour RJ. Anthelmintic efficacy of triclabendazole against Fasciola hepatica in sheep. Vet Rec 1984;114:31-42.

  15. Van den Bossche H, Rochelle E, Horig C. Mebendazole and related anthelmintics. Adv Pharmacol Chemother 1982;19:67-73.

  16. Chauvin A. Responses immunitaires locale et générale chez le mouton infesté expérimentalement par Fasciola hepatica Linné, 1758 (tesis doctoral). Tours (France): Univ Tours, 1994.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Vet Mex. 1997;28